selenomethionine has been researched along with Adenocarcinoma in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (28.57) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 8 (38.10) | 29.6817 |
| 2010's | 6 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guillen, KP; Harrison, RG; Kurkjian, C; Restuccia, A | 1 |
| Cecchini, MG; Klima, I; Peternac, D; Schwaninger, R; Studer, UE; Thalmann, GN | 1 |
| Gangapurkar, B; Jariwalla, RJ; Nakamura, D | 1 |
| Bonorden, MJ; Cleary, MP; Hu, H; Lee, HJ; Li, GX; Liao, JD; Lü, J; Wang, L; Zhang, Y | 1 |
| Bosland, MC; Johnson, WD; Lubet, RA; McCormick, DL; Rao, KV; Steele, VE | 1 |
| Bosland, MC; Horton, L; Lasano, S; Ozten, N | 1 |
| Anderson, LB; Lü, J; Wang, L; Witthuhn, B; Xu, Y; Zhang, J | 1 |
| Echigo, S; Endo, M; Rikiishi, H; Shinohara, F; Suzuki, M | 1 |
| Ishii, PL; Mantovani, MS; Mauro, MO; Oliveira, RJ; Ribeiro, LR; Sartori, D | 1 |
| Brodzeller, T; Datta, MW; Dhir, R; Hessner, MJ; Liu, H; Matysiak, B; Pollard, M; Schlicht, M; Suckow, M; Tonellato, P; Wen, X; Zhou, G | 1 |
| Attar, BM; Atten, MJ; Holian, O; Verma, A | 1 |
| Altundag, K; Altundag, O; Gundeslioglu, O; Gunduz, M; Silay, YS; Yigitbasi, OG | 1 |
| Basler, JW; Caton, JR; Crawford, ED; Lee, JJ; Lerner, SP; Lippman, SM; Marshall, JR; Menter, DG; Miles, BJ; Minasian, LM; Pisters, LL; Sabichi, AL; Tangen, CM; Taylor, RJ; Thompson, IM | 1 |
| Gabuniia, RI; Kuchinskiĭ, GA; Petsko, AR; Vinogradov, VA | 1 |
| Avis, FP; Avis, IL | 1 |
| Glukhov, IuD; Nazar'ey, BM | 1 |
| Hirose, Y; Kelloff, GJ; Lubet, RA; Rao, CV; Reddy, BS; Steele, VE | 1 |
| Drozdovskaja, MI; Gabunija, RI; Goldobenko, GV; Kudrjavzeva, GT; Matveenko, EG; Prichodjko, AG; Senjukov, MV; Vtjurin, BM | 1 |
| Granville, GE; Gyorkey, F; Min, KW; Pircher, FJ; Waddell, CC | 1 |
| Hung, MC; Klostergaard, J; Rodriguez, RU; Suen, TC | 1 |
| Chanachai, W; Mohd, S; Reisfeld, RH; Shani, J; Walker, LE; Wolf, W | 1 |
1 trial(s) available for selenomethionine and Adenocarcinoma
| Article | Year |
|---|---|
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Middle Aged; Prostate; Prostatectomy; Prostatic Neoplasms; Selenium; Selenomethionine; Seminal Vesicles; Sensitivity and Specificity; Spectrometry, Fluorescence; Time Factors; Tissue Distribution | 2006 |
20 other study(ies) available for selenomethionine and Adenocarcinoma
| Article | Year |
|---|---|
Annexin V-Directed Enzyme Prodrug Therapy Plus Docetaxel for the Targeted Treatment of Pancreatic Cancer.
Topics: Adenine; Adenocarcinoma; Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Carbon-Sulfur Lyases; Cell Death; Cell Line, Tumor; Cytosine Deaminase; Docetaxel; Dose-Response Relationship, Drug; Enzymes; Flucytosine; Fluorouracil; Humans; Methanol; Molecular Targeted Therapy; Organoselenium Compounds; Pancreatic Neoplasms; Prodrugs; Purine-Nucleoside Phosphorylase; Recombinant Fusion Proteins; Selenomethionine; Taxoids; Tubulin Modulators; Vidarabine | 2015 |
Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
Topics: Adenocarcinoma; alpha-Tocopherol; Anticarcinogenic Agents; beta Carotene; Biomarkers, Tumor; Carotenoids; Cell Line, Tumor; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Genistein; Humans; Lycopene; Male; Prostate-Specific Antigen; Prostatic Neoplasms; RNA, Messenger; Selenomethionine; Vitamins | 2008 |
Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium.
Topics: Adenocarcinoma; Adolescent; Adult; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Cysteine; Epithelial Cells; Female; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Neuroectodermal Tumors, Primitive, Peripheral; Organoselenium Compounds; Selenium Compounds; Selenocysteine; Selenomethionine; Skin Neoplasms | 2009 |
Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Proliferation; Cysteine; Enzyme-Linked Immunosorbent Assay; In Situ Nick-End Labeling; Insulin-Like Growth Factor I; Male; Mice; Mice, Transgenic; Organoselenium Compounds; Prostatic Neoplasms; Selenocysteine; Selenomethionine | 2009 |
Null activity of selenium and vitamin e as cancer chemopreventive agents in the rat prostate.
Topics: Adenocarcinoma; Alkylating Agents; alpha-Tocopherol; Androgens; Animals; Antioxidants; Cyproterone Acetate; Disease Models, Animal; Drug Therapy, Combination; Male; Methylnitrosourea; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Rats; Rats, Wistar; Selenium Compounds; Selenomethionine; Testosterone; Vitamin E | 2010 |
Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model.
Topics: Adenocarcinoma; alpha-Tocopherol; Androgens; Animals; Antioxidants; Dietary Supplements; Disease Models, Animal; Drug Therapy, Combination; Estradiol; Estrogens; Male; Oxidative Stress; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Selenomethionine; Testosterone | 2010 |
Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model.
Topics: Adenocarcinoma; Animals; Biomarkers, Pharmacological; Biomarkers, Tumor; Cysteine; Disease Models, Animal; Male; Metabolome; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Biological; Organoselenium Compounds; Prostatic Neoplasms; Proteomics; Selenium Compounds; Selenocysteine; Selenomethionine | 2010 |
Rapamycin suppresses ROS-dependent apoptosis caused by selenomethionine in A549 lung carcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Microtubule-Associated Proteins; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Selenomethionine; Signal Transduction; Sirolimus; Sodium Selenite; TOR Serine-Threonine Kinases | 2011 |
Activity of selenium on cell proliferation, cytotoxicity, and apoptosis and on the expression of CASP9, BCL-XL and APC in intestinal adenocarcinoma cells.
Topics: Adenocarcinoma; Adenomatous Polyposis Coli Protein; Apoptosis; bcl-X Protein; Caspase 9; Cell Proliferation; Cell Survival; Cells, Cultured; Doxorubicin; Drug Synergism; Gene Expression; HT29 Cells; Humans; Selenium; Selenomethionine | 2011 |
Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Cell Line, Tumor; DNA, Neoplasm; Expressed Sequence Tags; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Protein 3; Male; Neoplasm Proteins; Prostatic Neoplasms; Rats; Retinoid X Receptor alpha; RNA, Messenger; RNA, Neoplasm; Selenium; Selenomethionine; Species Specificity; Subtraction Technique | 2004 |
Selenomethionine stimulates MAPK (ERK) phosphorylation, protein oxidation, and DNA synthesis in gastric cancer cells.
Topics: Adenocarcinoma; Apoptosis; Cell Division; DNA; Enzyme Activation; Humans; Mitogen-Activated Protein Kinase Kinases; Oxidative Stress; Phosphorylation; Selenomethionine; Stomach Neoplasms; Tumor Cells, Cultured | 2004 |
Selenium supplementation may increase the efficacy of cetuximab in metastatic colorectal cancer patients.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Depression, Chemical; Dietary Supplements; Dinoprostone; Drug Synergism; ErbB Receptors; Humans; Irinotecan; Membrane Proteins; Models, Biological; Neoplasm Proteins; Organoplatinum Compounds; Oxaliplatin; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Protein Processing, Post-Translational; Selenium; Selenomethionine; Signal Transduction | 2005 |
[Angioscintigraphic examinations of pancreatic tumours (author's transl)].
Topics: Adenocarcinoma; Adenoma, Islet Cell; Angiography; Gold Colloid, Radioactive; Humans; Pancreas; Pancreatic Cyst; Pancreatic Neoplasms; Radionuclide Imaging; Selenomethionine | 1980 |
A modification of the (75Se) selenomethionine assay for the detection of complement-dependent antibody in human tumor systems.
Topics: Adenocarcinoma; Antibodies, Neoplasm; Breast Neoplasms; Carcinoma, Transitional Cell; Cell Line; Cytotoxicity Tests, Immunologic; Female; Humans; Kidney Neoplasms; Selenium; Selenomethionine; Urinary Bladder Neoplasms | 1983 |
[Use of selenomethionine in the diagnosis of malignant tumors of the kidneys].
Topics: Adenocarcinoma; Aged; Diagnosis, Differential; Humans; Kidney Diseases, Cystic; Kidney Neoplasms; Male; Radionuclide Imaging; Selenium; Selenomethionine | 1982 |
Lack of chemopreventive efficacy of DL-selenomethionine in colon carcinogenesis.
Topics: Adenocarcinoma; Adenoma; Animals; Azoxymethane; Colonic Neoplasms; Diet; Male; Rats; Rats, Inbred F344; Selenomethionine | 2000 |
[Positive tumour scintigraphy (author's transl)].
Topics: Adenocarcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Cheek; Gallium Radioisotopes; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Mandibular Neoplasms; Maxillary Neoplasms; Maxillary Sinus; Mouth Mucosa; Paranasal Sinus Neoplasms; Radionuclide Imaging; Selenomethionine; Technetium | 1979 |
Selective uptake of 75Se-selenomethionine by thymoma with pre red cell aplasia.
Topics: Adenocarcinoma; Anemia, Aplastic; Diagnosis, Differential; Gallium Radioisotopes; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Radionuclide Imaging; Selenium; Selenomethionine; Thymoma; Thymus Neoplasms; Thyroid Neoplasms | 1978 |
V-abl confers resistance and growth advantage to TNF-alpha in NIH3T3 cells.
Topics: Adenocarcinoma; Animals; Cell Line, Transformed; Cell Survival; Cytotoxicity, Immunologic; Drug Resistance; Macrophages; Mice; Neutral Red; Oncogene Proteins v-abl; Oncogenes; Recombinant Proteins; Retroviridae Proteins, Oncogenic; Selenomethionine; Tumor Necrosis Factor-alpha | 1990 |
Labeling and comparative biodistribution of the monoclonal antibody KS1/4 in nude mice bearing human lung adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Humans; Indium; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Pentetic Acid; Radioisotopes; Radionuclide Imaging; Selenium; Selenomethionine; Tissue Distribution; Transplantation, Heterologous | 1986 |